Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Advanced Drug Delivery Reviews
|
January 13, 2009
ABCG2: a perspective
Robert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
Robert W Robey, Suneet Shukla, Kenneth Steadman, et al.
International Journal of Molecular Sciences
|
May 31, 2020
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
Crystal C Lipsey, Adriana Harbuzariu, Robert W Robey, et al.
Nature Reviews. Cancer
|
April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
Susan E Bates, Wilma Y Medina-Pérez, Glenda Kohlhagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2017
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma"
Erkut Borazanci, Chi V Dang, Robert W Robey, et al.
Molecular and Cellular Biochemistry
|
November 13, 2008
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant
Orsolya Polgar, John F Deeken, Lilangi S Ediriwickrema, et al.
Cytometry
|
July 13, 2002
Flow cytometric analysis of breast cancer resistance protein expression and function
Hans Minderman, Attaya Suvannasankha, Kieran L O'Loughlin, et al.
Cancer Research
|
April 5, 2012
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter
Agnes Basseville, Akina Tamaki, Caterina Ierano, et al.
Molecular Pharmacology
|
November 7, 2007
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan
Zhiyong Liao, Robert W Robey, Josée Guirouilh-Barbat, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Advanced Drug Delivery Reviews
|
January 13, 2009
ABCG2: a perspective
Robert W Robey, Kenneth K K To, Orsolya Polgar, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
Robert W Robey, Suneet Shukla, Kenneth Steadman, et al.
International Journal of Molecular Sciences
|
May 31, 2020
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
Crystal C Lipsey, Adriana Harbuzariu, Robert W Robey, et al.
Nature Reviews. Cancer
|
April 13, 2018
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W Robey, Kristen M Pluchino, Matthew D Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
Susan E Bates, Wilma Y Medina-Pérez, Glenda Kohlhagen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2017
Pancreatic Cancer: "A Riddle Wrapped in a Mystery inside an Enigma"
Erkut Borazanci, Chi V Dang, Robert W Robey, et al.
Molecular and Cellular Biochemistry
|
November 13, 2008
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant
Orsolya Polgar, John F Deeken, Lilangi S Ediriwickrema, et al.
Cytometry
|
July 13, 2002
Flow cytometric analysis of breast cancer resistance protein expression and function
Hans Minderman, Attaya Suvannasankha, Kieran L O'Loughlin, et al.
Cancer Research
|
April 5, 2012
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter
Agnes Basseville, Akina Tamaki, Caterina Ierano, et al.
Molecular Pharmacology
|
November 7, 2007
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan
Zhiyong Liao, Robert W Robey, Josée Guirouilh-Barbat, et al.
Page
of 13